HYBRID EVENT: You can participate in person at Boston, Massachusetts, USA or Virtually from your home or work.

8th Edition of International Conference on Neurology and Brain Disorders

October 19-21, 2023

October 19 -21, 2023 | Boston, Massachusetts, USA
INBC 2023

Kledisa Shemsi

Speaker at Neurology and Brain Disorders 2023 - Kledisa Shemsi
Bezirkskliniken Schwaben, Germany
Title : Patients presented in emergency department of SRD with headache as symptom of covid-19


Background and Aims:
To see the patients presented in the Emergency Department of SRD with headache as a symptom of COVID-19.

We have seen frequency and characteristic of headache in 180 patients in an emergency with a test of polymerase chain reaction positive.

These patients are presented in period 1 August 2021 until 31 December 2022 with the headache as the first symptom of COVID – 19. The most of cases was reported in man 56% (101 patients) and mid-age of cases were 52.5years. The most of patients 62% (112 patients) had a very severe intensity of headache and it was diffuse or more in the frontal area (in 90% of these groups). 38 % of patients had moderate headache, and a part of all patients 22% (40 patients) had characteristics of migraine with hemicrania and nausea and vomitus and photophobia (this was seen more in patients that had experience migraine before, p < 0.05). In 25% of all patients (45) had continuous headaches without a period of free pain even after administration of analgesic therapy. A part of patients 34 % (61 patients) had anosmia as accompanied symptom. All cases had seen by a neurologist that did suggestions for all examinations that were neccesary.

In our Department of Emergency, we have seen a closed correlation of headaches with COVID-19. The most of patients had headache the only symptom in the first days of covid-19 and it was in general severe, diffuse, and in some patients as a migraine phenotype.


Will be Updated Soon...